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H-NS is a major Escherichia coli nucleoid-associated protein involved in bacterial DNA condensation and
global modulation of gene expression. This protein exists in cells as at least two different isoforms separable
by isoelectric focusing. Among other phenotypes, mutations in hns result in constitutive expression of the proU
and fimB genes, increased fimA promoter inversion rates, and repression of the flhCD master operon required
for flagellum biosynthesis. To understand the relationship between H-NS structure and function, we trans-
formed a cloned hns gene into a mutator strain and collected a series of mutant alleles that failed to repress
proU expression. Each of these isolated hns mutant alleles also failed to repress fimB expression, suggesting
that H-NS-specific repression of proU and fimB occurs by similar mechanisms. Conversely, alleles encoding
single amino acid substitutions in the C-terminal DNA-binding domain of H-NS resulted in significantly re-
duced affinity for DNA yet conferred a wild-type fimA promoter inversion frequency, indicating that the mech-
anism of H-NS activity in modulating promoter inversion is independent of DNA binding. Furthermore, two
specific H-NS amino acid substitutions resulted in hypermotile bacteria, while C-terminal H-NS truncations
exhibited reduced motility. We also analyzed H-NS isoform composition expressed by various hns mutations
and found that the N-terminal 67 amino acids were sufficient to support posttranslational modification and
that substitutions at positions 18 and 26 resulted in the expression of a single H-NS isoform. These results are
discussed in terms of H-NS domain organization and implications for biological activity.
H-NS is a major component of the Escherichia coli nucleoid
originally isolated by its ability to bind and compact chromo-
somal DNA (10, 34, 35, 44). This small (15.4 kDa), abundant
(20,000 copies/cell), neutral (pI, ;7.5), heat-stable protein
binds avidly to double-stranded (ds) DNA with higher affinity
for curved DNA substrates (30, 37, 46). H-NS is a global
modulator of gene expression affecting the synthesis, both pos-
itively and negatively, of more than 50 E. coli proteins (3, 22,
47). In addition, H-NS is also involved in regulating expression
of virulence-associated genes in pathogenic Shigella spp. (25,
31), Salmonella spp. (15), and enteroinvasive E. coli (5, 32).
In the best-characterized H-NS-sensitive systems, such as
proU (16, 26, 40), fimB (9), bgl (6), and pap (14), gene expres-
sion is derepressed in hns insertion mutant strains. Often H-NS
acts as a transcriptional repressor binding to intrinsically
curved DNA sequences located near prokaryotic promoters
(37). In solution, H-NS acts as a homodimer and can form
higher-order oligomers at increased protein concentrations
(12, 34). Multimerization has recently been shown to be critical
for H-NS repressor function at both the proU and hns promot-
ers (36, 41).
In light of the fact that H-NS is found in a cross-section of
bacterial species (43) and is part of global regulatory networks
involved in virulence, metabolism, and environmental stress,
yet contains no known structural peptide motifs (such as zinc
finger or helix-turn-helix motifs), we randomly mutagenized
hns to help delineate biologically active H-NS domains. To
clarify protein structure and function, we examined H-NS iso-
form composition and the action of H-NS in the processes of
piliation and motility, as well as the more frequently studied
roles of DNA binding and gene repression.
MATERIALS AND METHODS
Bacterial strains, plasmids, media, genetic techniques, and enzyme assays.
The bacterial strains and plasmids used in this study are listed in Table 1. H-NS
mutant derivatives are listed in Table 2. Media consisted of Luria-Bertani (LB)
broth, LB agar, and MacConkey agar (Difco, Detroit, Mich.). When used, anti-
biotics were added to a final concentration of 100 mg (ampicillin) or 20 mg
(tetracycline or chloramphenicol) per ml of medium. Restriction and other
DNA-modifying enzymes were used as instructed by the manufacturers (Gibco-
BRL, Gaithersburg, Md.; New England Biolabs, Beverly, Mass.; and Boehringer
Mannheim, Indianapolis, Ind.). b-Galactosidase assays were performed as de-
scribed elsewhere (27) with strains grown in LB broth.
Plasmid construction and hns mutagenesis. Plasmid pTHK116-7 was gener-
ated to serve as the hns template for the mutagenesis as follows. Plasmid
pTHK116 was linearized by EcoRI digestion, blunt-ended with T4 DNA poly-
merase, and ligated to BamHI linkers (Stratagene, La Jolla, Calif.). The 1.8-kb
hns fragment was released by BamHI-SalI digestion, gel purified (Qiagen, Chats-
worth, Calif.), and cloned into the BamHI-SalI sites of pACYC184. The ligation
reaction was transformed into DH5a, and colonies were selected on chloram-
phenicol plates. DNA from Cmr Tets transformants was subsequently verified by
PCR screening and restriction digestion.
The hns gene was randomly mutated by transforming and propagating
pTHK116-7 in the mutD mutS mutT strain XL1-Red as suggested by the man-
ufacturer (Stratagene). Plasmid DNA was purified (Qiagen) from Cmr transfor-
mants, retransformed into the indicator strain THK62, and plated on lactose
MacConkey medium. Plasmid DNA from these strains was verified to contain
hns by HpaI digestion and sequenced to determine the mutations with forward 59
CAG TCC TGC TCG CTT CGC 39 and reverse 59 GGT GTT ATC CAC GAA
ACG GC 39 primers.
Motility, gel shift assays, and protein purifications. Motility was assayed by
measuring swarm diameters as previously described (8) except measurements
were taken at only one time point. Gel shift assays and H-NS purifications were
done as previously described (9) except the mutant protein lysate (T108I) was
washed from the ds-DNA-cellulose column with a 125 mM NaCl solution.
Two-dimensional gel electrophoresis. Whole-cell lysates were prepared by
using a French pressure cell as previously described (9). Samples were dissolved
in O’Farrell’s solution (28) containing 1.5% pH 5 to 7 and 0.5% pH 3 to 10
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ampholytes (Bio-Rad, Hercules, Calif.) and focused in the first dimension in tube
gels according to the manufacturer’s instructions (Hoefer Scientific Instruments,
San Francisco, Calif.). After isoelectric focusing (IEF), proteins in the extracted
tubes were separated in the second dimension by sodium dodecyl sulfate–15%
polyacrylamide gel electrophoresis, transferred to nitrocellulose, probed with
H-NS antiserum, and detected as described previously (9). Some filters were
probed with H-NS antiserum preadsorbed against an hns2 tetR strain in order to
eliminate cross-reactivity to non-H-NS proteins.
RESULTS
Isolation of hns mutations. H-NS is a global regulator of a
variety of unlinked and unrelated genes in E. coli and Salmo-
nella typhimurium (2, 43). Mutations in hns are pleiotropic,
affecting the synthesis of a vast array of gene products involved
in numerous biological processes (3, 22, 47). In an attempt to
define and correlate separate H-NS domains with different
biological activities, we subjected hns to a random mutagenesis
scheme followed by an in vivo genetic screen to isolate a series
of hns mutants.
We constructed plasmid pTHK116-7 (Table 1) to serve as
the low-level hns-expressing template for the mutagenesis in
order to avoid the potentially deleterious effects of overex-
pressing mutant hns protein products in the cell (35). This
clone carried the wild-type hns gene driven by the down-reg-
ulated hns-1 promoter mutation (19) in the low-copy-number
vector pACYC184. Plasmid pTHK116-7 was transformed into
a triple-repair-deficient E. coli mutator strain (XL1-Red) to
generate spontaneous, random mutations. Approximately 100
antibiotic-resistant colonies were picked, and plasmid DNA
was purified from each of these transformants and individually
retransformed into strain THK62 carrying a chromosomal
hns2-tetR insertion mutation and proU9-lacZ transcriptional
fusion (Table 1). H-NS is a direct transcriptional repressor of
proU (16, 23, 40), and expression is phenotypically detectable
in strains with proU-lacZ fusions on lactose MacConkey indi-
cator medium. Thus, our strategy was to select for mutations
that were unable to complement the hns2-tetR mutation and
therefore represented the derepression of proU expression
(Lac1, red colony phenotype). Seventy-one red THK62-based
transformants from lactose MacConkey plates were chosen as
putative hns mutant candidates.
To ensure that these potential hns mutations encoded stable
proteins and to study point mutations rather than large gene
deletions, we probed mutant strains with anti-H-NS antiserum
in Western blots (data not shown). H-NS from 29 of 71 strains
reacted with anti-H-NS antibody with 25 isolates producing
apparently full-length protein on SDS-PAGE. We transformed
plasmids representing 17 hns isolates into a clean background
strain (XL1-Blue) and sequenced the DNA. We found seven
independent missense and five nonsense mutations, which all
maintained the original pTHK116-7 promoter sequence. The
remaining five isolates expressed duplicate hns mutations.
Each missense mutation encoded inferred single amino acid
substitutions while the nonsense mutations resulted in C-ter-
minally truncated forms of H-NS (Table 2).
Effects of hns mutations on gene expression. We measured
b-galactosidase activity (27) from THK62 carrying each hns
mutant allele to quantitate the effects of the mutations on proU
expression (Fig. 1A). As expected, proU-lacZ expression in-
creased significantly in all hns mutant strains tested, albeit to
various degrees. We also examined the effects of these muta-
tions on fimB expression by using a fimB-lacZ fusion strain
(AL90). We have recently shown that H-NS acts as a repressor
of fimB expression by directly binding to the promoter region
and inhibiting transcription (9). As with proU, fimB-lacZ ex-
pression was 6- to 30-fold higher in the hns mutant strains
relative to that of the wild-type hns-expressing strain (Fig. 1B).
Similar trends develop if one compares the level of derepres-
sion of both promoters over the course of each hns mutation.
That is, each hns mutation affected proU and fimB expression
in a similar fashion. For example, hnsL26P greatly increased
expression whereas hnsT108I and hnsA18E resulted in the least
severe mutant phenotypes at both promoter fusions. We con-
cluded that (i) all of the hns mutations isolated induced proU
and fimB expression, (ii) these mutants were defective in their
repression ability, and (iii) H-NS probably employs similar
repression mechanisms at each promoter.
Effects of hns mutations on fimA promoter inversion. In
order to sort our series of hns mutants into separate pheno-
typic classes we tested their effects on fimA promoter inversion.
Type 1 pilus expression is controlled transcriptionally by the
inversion of a DNA element encompassing the fimA promoter






THK38 thr-1 leuB thi-1 D(argF-lac)U169 malA1
xyl-7 ara-13 mtl-2 gal-6 rpsL fhuA2
supE44 hns1, linked to tetR
18
THK62 THK38 except F(proU9-lacZYA-kan)
hns2-tetR
18
ORN116 THK38 except F(fimA9-lacZYA-kan)
hns-1
29
AL90 MG1655 DlacZYA hns2-tetR fimB-
lacZYA
9
AL29 ORN116 except hns2-tetR 29
XL1-Red endA1 gyrA96 thi-1 hsdR17 supE44 relA1
lac mutD5 mutS mutT Tn10(Tetr)
Stratagene
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44








pTHK116 pBR322 with wild-type hns gene under
control of hns-1 promoter mutation,
Ampr
19
pTHK116-7 pACYC184 with 1.8-kb EcoRI-SalI hns
encompassing fragment from pTHK116
This study
TABLE 2. Sequence analysis of hns mutations
H-NS










N67 1-bp insertion causing frameshift and new sequence
encoding 64MLIA67364NADR67 before early stop
codon
1
N82 AAA3TAA stop codon 1
N93 CCG3TGA stop codon 1
N123 2-bp deletion causing frameshift and new sequence
encoding 122AM3122DG before early stop codon
1
N124 1-bp insertion causing frameshift and new sequence
encoding 122AMD3122SNG before early stop codon
3
a In order to maintain consistency with previously published mutants (41, 42,
45), the initial methionine is represented by amino acid position no. 1. Deriva-
tives N67, N82, N93, N123, and N124 are N-terminal truncations.
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(1, 11). Piliation is phase variable (on N off), and changes in
expression may be monitored phenotypically on lactose Mac-
Conkey agar (29). Individual colonies from wild-type strains
carrying a fimA9-lacZ fusion are either red (Lac1, fimA pro-
moter on) or white (Lac2, fimA promoter off). Our laboratory
has previously shown that hns mutations cause a 100-fold in-
crease in the fimA promoter inversion rate, yielding pink col-
onies consisting of approximately equal numbers of on and off
promoter-oriented cells (18, 19).
The hns mutations fell into two classes in regards to fimA
promoter inversion (Table 3). The point mutations in the C-
terminal third of the protein did not affect inversion, whereas
FIG. 1. Effects of hns mutant alleles on gene expression. All strains containing either proU-lacZ (THK62) (A) fimB-lacZ (AL90) (B) fusions and the indicated hns
plasmids were grown to mid-log phase at 30°C and assayed for b-galactosidase activity (27). Data represent the averages of three to four independent experiments in
duplicate. Error bars, standard errors of the means.
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the remaining four point mutations and three C-terminal trun-
cations all resulted in the mutant, rapid promoter-inversion
phenotype. It has been well documented that the DNA-binding
domain is located in the C terminus of H-NS (33, 42). Thus,
our results suggest that H-NS regulated type 1 pilus promoter
inversion by some non-DNA-binding mechanism. We con-
cluded that the ability of H-NS to control promoter flipping
resides in the N-terminal half of the protein and that the C
terminus may be needed only for some undefined role.
Effects of hns mutations on motility. H-NS is a positive
regulator of flhCD, the master operon which controls the ex-
pression of all flagellar genes required for motility (24). Mu-
tations in hns render bacteria nonmotile due to the reduced
expression of flhCD and subsequent lack of flagellar biogenesis
(4, 17, 20). Strains harboring each of the hns plasmids were
inoculated onto semisolid agar plates and incubated at 30°C
for 13 to 17 h. Motility was determined by measuring the
diameter of the bacterial swarms and calculating a relative rate
(Table 4). Most of the mutations had no major effect on mo-
tility with swarm rates close to 1. However the two hns point
mutations A18E and T108I exhibited a unique hypermotile
phenotype. We independently analyzed the basis for this hy-
permotile phenotype and determined that A18E and T108I
affected flagellar rotational speed (8). Three other mutants
were severely defective in the ability to move through the soft
agar. The initial M1I mutant was completely nonmotile and
two truncations, N93 and N124, displayed two- to threefold de-
creases in motility rates, respectively. These results suggested
that the carboxy-terminal portion of H-NS may be involved in
some aspect of bacterial motility that does not necessarily
include DNA binding.
DNA-binding activity of altered H-NS protein. One of the
most extensively studied properties of H-NS is its ability to
bind DNA, since this interaction is often coupled to gene reg-
ulation (9, 38, 40). Combined genetic and biochemical efforts
have isolated the DNA-binding region of H-NS to the C-ter-
minal third of the protein (33, 42). We performed gel shift
assays to compare the binding affinities of wild-type H-NS to
protein encoded by hns with a mutation in the proposed DNA-
binding fragment (T108I). Equal and increasing amounts of
each purified protein were added to a known H-NS target, the
fimB promoter (9) (Fig. 2).
In agreement with our previous study on H-NS–fimB inter-
actions (9), we determined that (i) wild-type H-NS avidly
bound the fimB promoter fragment, (ii) binding occurred at a
low protein-to-DNA molar ratio, indicating a high-affinity
binding capacity, and (iii) there were multiple H-NS binding
sites within the fimB promoter region. In contrast, H-NS en-
coded by hnsT108I was unable to bind and retard fimB DNA.
Even at the maximum protein concentrations added, com-
plexes were undetectable even though the intensity of free DNA
slightly decreased. These results demonstrated that H-NST108I
is defective in its ability to bind relevant fimB DNA and corro-
borates evidence that the H-NS C terminus is essential for this
function.
H-NS isoforms. In the cell, H-NS exists as two or three
isoforms differing only in their pI values (21, 34, 43). Presum-
ably, H-NS undergoes a posttranslational modification, yet the
type and site of modification and biological function of each
form is still unknown. To begin uncovering these details we
subjected whole-cell lysates of the hns mutant strains to two-
dimensional electrophoresis followed by H-NS identification
via Western blot analysis (Fig. 3). We consistently observed
two isoforms present at 15.4 kDa that reacted with anti-H-NS
antiserum in the wild-type hns strain (Fig. 3A) but absent in
the vector-only control (Fig. 3B). The same two polypeptides
were also synthesized from the hnsT108I mutant allele (Fig.
3C). Two low-intensity H-NS specific spots were also visible
with the N67 derivative (Fig. 3D). This mutation encodes a
C-terminally truncated form of H-NS that is approximately
7 kDa. However, each of the N-terminal point mutations,
A18E and L26P, yielded only one H-NS isoform (Fig. 3E and
F, respectively). Thus, these results suggested that the H-NS
modification site is located within the amino half of the pro-
tein, potentially near residues 18 to 26.
DISCUSSION
In this study, we combined genetic and biochemical ap-
proaches to identify key H-NS features necessary for a number
of different functions. Transforming an hns-bearing plasmid
into an E. coli mutator strain provided a simple method to
obtain a set of random hns mutations. This technique, as op-
posed to chemical mutagenesis, had the advantage of being
truly random and unbiased. We isolated hns mutant alleles
with base pair insertions, deletions, transitions, and transver-
sions which resulted in the alteration of different individual
amino acid residues (Table 2). The locations of these amino
acid substitutions and their effects on various H-NS activities
allowed us to construct a model of H-NS domain organization
(Fig. 4).
As anticipated, all of the hns mutations isolated were defec-
TABLE 3. Effects of hns mutations on fimA promoter inversiona
H-NS derivative Inversion phenotype
pTHK116-7 (wild-type hns) Red and white (normal)





R93H Red and white
T108I Red and white




a All plasmids were transformed into AL29 (fimA9lacZYA-kan, hns2-tetR) and
grown at 37°C on lactose MacConkey indicator medium. Individual colonies
were picked and restruck to verify phenotypes.
TABLE 4. Effects of hns mutations on motility
H-NS derivative Relative motility ratea
pACYC184 (vector) 0.20 6 .05
M1I 0.17 6 .03
A18E 2.50 6 .17
L26P 0.79 6 .17
L65P 0.80 6 .11
R93H 0.99 6 .15
T108I 2.10 6 .21
G111S 0.94 6 .20
N67 0.60 6 .13
N93 0.43 6 .06
N124 0.32 6 .08
a Motility rates were determined by comparing the swarm diameters of the
hns2-tetR strains expressing the mutant hns plasmids relative to those of the same
strains, on the same plates, expressing the wild-type hns plasmid. A swarm rate
of 1 indicates identical swarm sizes between the two strains. Data represent the
means 6 standard errors of the means for five to seven individual experiments.
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tive in their ability to repress the expression of both proU- and
fimB-lacZ promoter fusions (Fig. 1). The magnitude of induc-
tion varied greatly between mutations with the major differ-
ence between test promoters being that proU expression was
;10 times more repressed by wild-type H-NS than fimB.
Moreover, individual hns mutations had equivalent effects at
both promoters. This observation led us to postulate that the
mode of operation of repression is probably the same for genes
at which H-NS has been shown to be a direct transcriptional
inhibitor such as fimB (9), proU (40), and rrnB (38). Other
investigators have suggested alternate mechanisms for H-NS
repression of the semi-synthetic gal promoter (45) and the bgl
operon (42).
Since its discovery (34, 44), the ability to bind DNA has been
FIG. 2. Gel shift assay comparing the DNA-binding abilities of wild-type H-NS and altered T108I H-NS. Each lane contains 1.6 pM fimB promoter DNA and the
indicated amount of either wild-type or T108I H-NS. Reaction mixtures were incubated, electrophoresed on a 1% agarose gel, and stained with ethidium bromide (9).
M, FX174 marker.
FIG. 3. Identification of H-NS isoforms by two-dimensional gel electrophoresis. Shown are Western blots of H-NS lysates separated by pI in the first dimension and
by size in the second dimension and probed with anti-H-NS antiserum. All blots are in the same orientation with the same pI scale and protein standards indicated.
Arrows indicate H-NS isoforms. For some panels e.g., panel A, purified H-NS (pure H-NS) was included as an internal marker. The H-NS protein and derivatives used
were wild-type (A), vector (B), T108I (C), N67 (D), A18E (E), and L26P (F).
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a major focus of H-NS research. Based on the binding prop-
erties of an H-NS truncation containing only the C-terminal 47
amino acids of the protein (33) and analysis of H-NS mutants
(42), it has been established that the C-terminal third of H-NS
encompasses the DNA-binding domain. Two lines of evidence
generated here with our hnsT108I mutation confirmed these
data. First, during purification H-NS T108I did not bind as
tightly as wild-type H-NS to a ds-DNA-cellulose column (7),
dissociating at lower salt concentrations (data not shown). Sec-
ondly, in gel shift assays T108I did not bind a fimB promoter
fragment at a protein-to-DNA molar ratio upwards of 120:1
(Fig. 2). This result is in contrast to the strong binding exhib-
ited by a low 45:1 molar ratio of wild-type H-NS to the same
piece of DNA. Thus, our work on T108I complemented pre-
vious intrinsic fluorescence H-NS studies (13, 39) that sug-
gested that the proximal tryptophan-109 closely interacted with
DNA. The caveat of in vitro binding assays is that other factors
that may be present in the cell and necessary for efficient
protein binding may not be included. However, this problem is
minimized when comparing the binding affinities of two pro-
teins, such as wild-type and T108I H-NS, under the exact same
conditions. Also, as previously suggested (42), a defect in DNA
binding is only partially responsible for maximal gene dere-
pression. This observation is exemplified by the fact that H-NS
encoded by hnsT108I was unable to bind fimB DNA (Fig. 2)
yet this mutation caused the smallest increase in fimB-lacZ
expression (Fig. 1B).
The molecular mechanism by which H-NS influences pro-
moter inversion and type 1 piliation is unknown. By inversion
assays (Table 3) we showed that the residues within the N-
terminal half of H-NS were important for controlling inversion
since changing them resulted in a mutant inversion phenotype.
In contrast, inversion regulation was not dependent on DNA
binding since strains with altered proposed H-NS–DNA con-
tact sites (R93H, T108I, and G111S) retained the wild-type
inversion frequency. In particular, substitutions at Thr-108
(Fig. 2) and Gly-111 (42) have specifically been shown to cause
drastic reductions in the ability of H-NS to bind DNA yet
neither alteration adversely affected fimA promoter inversion
frequency. Interestingly, even though residues within the
DNA-binding domain of H-NS were not required for proper
fimA promoter flipping, the entire C-terminal half of the pro-
tein was needed in some capacity, as evidenced by the mutant
inversion phenotype exhibited by the H-NS truncations. We
postulate that H-NS regulates inversion without binding DNA,
possibly through protein-protein interactions with other mol-
ecules present at the fimA invertible element, and that the
C-terminal domain may be important for overall structural
integrity and protein stabilization. Data presented here also
corroborated our previous conclusion that the regulation of
FimB recombinase levels in the cell by H-NS is not the sole
cause of the rapid inversion witnessed in hns mutant back-
grounds (9). Consistent with this hypothesis, H-NS derivatives
R93H, T108I, and G111S caused 6- to 25-fold increases in fimB
expression (Fig. 1B) while maintaining a wild-type inversion
phenotype (Table 3).
As with inversion, the motility results (Table 4) implicated
the nonregulatory role of the H-NS carboxy terminus. The
negative effects of hns mutations on bacterial motility were
mainly clustered to the H-NS truncations, arguing that the
conformation of this domain, rather than individual residues, is
relevant to this motility phenotype. Rather than acting solely as
a transcriptional activator of flagellar gene expression (4) the
effect of H-NS on motility may be determined by protein in-
teractions between H-NS and flagellar rotor components, as
we have recently demonstrated with FliG (8).
Determining the type and location of the modified group(s)
of H-NS is valuable for devising a mechanistic view of multiple
H-NS activities. It is possible that separate H-NS isoforms
possess differential functions. Using two-dimensional gel anal-
ysis (Fig. 3), we showed for the first time that multiple isoforms
were present when an hns clone encoding only residues 1
through 67 was the sole source of H-NS expression. Further
H-NS analysis revealed that a potential modification site may
lie within or near a nine-residue span from A18 to L26. Thus,
alterations in these specific amino acids may directly interfere
with the addition of a modified group or cause local structural
rearrangements in proximal residues.
Utilizing a random mutagenesis scheme followed by multi-
ple phenotypic analyses, we have been able to aid in defining
the relationship between H-NS structure and function. Several
general themes have arisen from this study. The gene expres-
sion experiments in conjunction with the H-NS–DNA binding
assays have confirmed that the ability to bind DNA is only one
of the duties H-NS has in modulating gene expression. Taken
together, the effects of hns mutations and deletions on fimA
promoter inversion and bacterial motility suggested that the
H-NS C-terminal domain may have multiple functions includ-
ing involvement in protein-protein interactions as well as in-
teractions with DNA. In agreement with this concept, we have
recently shown that alterations in H-NS at residue 108 affect
binding to FliG (8) and Spurio et al. (36) have shown that
FIG. 4. Schematic representation of H-NS. Altered residues are indicated by position number and amino acid substitution. Truncations are denoted by vertical lines.
Rectangles represent domains involved in the indicated H-NS functions based on this study. The DNA-binding domain is as defined by Ueguchi et al. (42). Caret
denotes residue implicated in DNA binding in this study; asterisks represent potential sites of H-NS modification.
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changes and deletions at Pro-116 impair H-NS oligomeriza-
tion. We also speculate that the N and C termini may interact
with each other, and we await determination of the three-
dimensional crystal structure of H-NS to test this hypothesis.
Although some H-NS functions may be isolated to particular
domains, it seems likely that all portions of the protein work
coordinately and in concert with each other to exert full H-NS
activity.
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